Crenezumab
Product Specifications
CAS Number
1095207-05-8
Target
Beta Amyloid
Related Pathways
Neuroscience
Purity
0.975
Bioactivity
Crenezumab (MABT 5102A) is a fully humanized anti-amyloid-beta antibody that binds to multiple forms of amyloid-beta (Aβ) for the study of Alzheimer's disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
